Drug reference
Piracetam
CNS Stimulant · CNS Stimulant and Cognition Enhancer
CNS StimulantCNS Stimulant and Cognition Enhancer
CDSCO approvedSchedule H
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
or females of childbearing potential,
FDA category + note
Mechanism
Piracetam is purported to be a cognition enhancer. The exact mechanism of action is not detailed in the provided texts.
Indications
Myoclonic seizures (adjunctive treatment)Alzheimer’s disease (AD)Multi-infarct dementia (MID)Mild cognitive impairment (MCI)Common symptoms of the elderly (dizziness and episodic memory lapses)Mental retardation in childrenLearning defectsAttention deficit disorderTransient ischaemic attacks (TIAs)Cerebrovascular accidentsStrokeOrganic psychosyndromesSequelae of head injuryElectroconvulsive therapy (ECT)Brain surgery
Dosing
- Adult
- seizures of juvenile myoclonic epilepsy. Adult dosing can begin with 500 or 1000 mg/d. The dosage can be increased every 2–4 weeks by 1000 mg to a. maximum dosage of 3000 mg/d. The drug is dosed twice daily. Adverse effects include somnolence, asthenia, ataxia, infection (colds), and dizziness.. exhibits linear pharmacokinetics over a wide dose range (10–600 mg, single oral dose).…
Pregnancy & lactation
Pregnancy
or females of childbearing potential,
Drug interactions
11 additional unreviewed or low-confidence interactions hidden because their provenance or source detail is insufficient.
Related guidelines
Other CNS Stimulant drugs
Ask House about Piracetam
Continue into a citation-backed clinical answer with the drug context already attached.
Textbook-sourced·Sources: Katzung·Updated: 2026-05-13